Regarding miR-34c, Achari and colleagues demonstrated that miR-34c exert tumour-suppressive effects in breast cancer through different mechanisms, such as induction of G2/M cell cycle arrest and suppression of the pro-survival factors BCL2 or SIRT1 [56]. Here, SIRT1 is linked to breast cancer.